The  	The  	 DT	O
science  	science  	 NN	O
and  	and  	 CC	O
manufacturing  	manufacturing  	 NN	O
behind  	behind  	 IN	O
botulinum  	botulinum  	 JJ	B-NP
neurotoxin  	neurotoxin  	 JJ	I-NP
type  	type  	 NN	I-NP
A-ABO  	A-ABO  	 NN	I-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
use  	use  	 NN	I-NP
Since  	Since  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
comprehensive  	comprehensive  	 JJ	B-NP
description  	description  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
physiologic  	physiologic  	 JJ	I-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
botulism  	botulism  	 JJ	O
toxicity  	toxicity  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
1820s 	1820s 	 NNP	O
,  	,  	 ,	O
specific  	specific  	 JJ	O
formulations  	formulations  	 NNS	B-NP
of  	of  	 IN	I-NP
botulinum  	botulinum  	 JJ	I-NP
neurotoxin  	neurotoxin  	 JJ	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
( 	( 	 -LRB-	O
BoNT-A 	BoNT-A 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
been  	been  	 VBN	O
developed 	developed 	 VBN	O
.  	.  	 .	O
Now 	Now 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
new  	new  	 JJ	O
botulinum  	botulinum  	 JJ	B-NP
neurotoxin  	neurotoxin  	 JJ	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
formulation  	formulation  	 NN	B-NP
( 	( 	 -LRB-	O
BoNTA-ABO 	BoNTA-ABO 	 NNP	B-NP
;  	;  	 :	O
Dysport  	Dysport  	 NNP	B-NP
[ 	[ 	 -LRB-	O
abobotulinumtoxinA 	abobotulinumtoxinA 	 NNP	B-NP
] 	] 	 -RRB-	O
;  	;  	 :	O
Medicis  	Medicis  	 NNP	B-NP
Aesthetics 	Aesthetics 	 NNP	I-NP
,  	,  	 ,	O
Scottsdale 	Scottsdale 	 NNP	B-NP
,  	,  	 ,	O
AZ 	AZ 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
made  	made  	 VBN	O
available  	available  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
and  	and  	 CC	O
these  	these  	 DT	O
same  	same  	 JJ	O
physiologic  	physiologic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
have  	have  	 VBP	O
become  	become  	 VBN	O
beneficial  	beneficial  	 JJ	O
clinical  	clinical  	 JJ	B-NP
targets 	targets 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
formulation  	formulation  	 NN	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
used  	used  	 VBN	O
successfully  	successfully  	 RB	O
for  	for  	 IN	O
nearly  	nearly  	 RB	O
20  	20  	 CD	O
years  	years  	 NNS	O
in  	in  	 IN	O
Europe  	Europe  	 NNP	O
and  	and  	 CC	O
other  	other  	 JJ	O
countries  	countries  	 NNS	O
under  	under  	 IN	O
the  	the  	 DT	O
trade  	trade  	 NN	B-NP
name  	name  	 NN	I-NP
Dysport  	Dysport  	 NNP	I-NP
( 	( 	 -LRB-	O
Clostridium  	Clostridium  	 NNP	B-NP
botulinum  	botulinum  	 JJ	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
toxin-hemagglutinin  	toxin-hemagglutinin  	 JJ	B-NP
complex 	complex 	 NN	I-NP
;  	;  	 :	O
Ipsen  	Ipsen  	 NNP	B-NP
Biopharm 	Biopharm 	 NNP	I-NP
,  	,  	 ,	O
Wrexham 	Wrexham 	 NNP	B-NP
,  	,  	 ,	O
UK 	UK 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
BoNT-A  	BoNT-A  	 JJ	B-NP
injections  	injections  	 NNS	I-NP
are  	are  	 VBP	O
administered  	administered  	 VBN	O
to  	to  	 TO	O
achieve  	achieve  	 VB	O
temporary  	temporary  	 JJ	O
local  	local  	 JJ	O
flaccid  	flaccid  	 JJ	B-NP
paralysis  	paralysis  	 NN	I-NP
of  	of  	 IN	O
targeted  	targeted  	 JJ	O
muscles 	muscles 	 NNS	O
.  	.  	 .	O
Injection  	Injection  	 NN	B-NP
of  	of  	 IN	I-NP
BoNT-A  	BoNT-A  	 JJ	I-NP
formulations  	formulations  	 NNS	I-NP
for  	for  	 IN	I-NP
aesthetic  	aesthetic  	 JJ	I-NP
purposes  	purposes  	 NNS	I-NP
was  	was  	 VBD	O
by  	by  	 IN	O
far  	far  	 RB	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
minimally-invasive  	minimally-invasive  	 NN	O
( 	( 	 -LRB-	O
nonsurgical 	nonsurgical 	 LS	B-NP
)  	)  	 -RRB-	O
cosmetic  	cosmetic  	 JJ	B-NP
procedure  	procedure  	 NN	I-NP
performed  	performed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
in  	in  	 IN	O
2008 	2008 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
review  	review  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
describe  	describe  	 VB	O
the  	the  	 DT	O
latest  	latest  	 JJS	O
data  	data  	 NNS	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
action  	action  	 NN	O
of  	of  	 IN	O
BoNTA-ABO 	BoNTA-ABO 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
roles  	roles  	 NNS	I-NP
of  	of  	 IN	I-NP
neurotoxin-associated  	neurotoxin-associated  	 JJ	I-NP
proteins  	proteins  	 NNS	I-NP
( 	( 	 -LRB-	O
NAP 	NAP 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
manufacturing  	manufacturing  	 NN	B-NP
standards  	standards  	 NNS	I-NP
for  	for  	 IN	O
these  	these  	 DT	O
biologic  	biologic  	 JJ	B-NP
products 	products 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
manufacturing  	manufacturing  	 NN	B-NP
process  	process  	 NN	I-NP
and  	and  	 CC	O
characteristics  	characteristics  	 NNS	O
of  	of  	 IN	O
BoNTA-ABO 	BoNTA-ABO 	 JJ	B-NP
.  	.  	 .	O
A  	A  	 DT	O
systematic  	systematic  	 JJ	B-NP
search  	search  	 NN	I-NP
using  	using  	 VBG	O
the  	the  	 DT	O
US  	US  	 NNP	O
National  	National  	 NNP	B-NP
Library  	Library  	 NNP	I-NP
of  	of  	 IN	O
Medicine  	Medicine  	 NNP	O
PubMed  	PubMed  	 JJ	B-NP
database  	database  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
relevant  	relevant  	 JJ	O
articles  	articles  	 NNS	O
were  	were  	 VBD	O
reviewed 	reviewed 	 VBN	O
.  	.  	 .	O
Direct  	Direct  	 JJ	B-NP
input  	input  	 NN	I-NP
and  	and  	 CC	O
data  	data  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
worldwide  	worldwide  	 JJ	O
manufacturer  	manufacturer  	 NN	B-NP
of  	of  	 IN	I-NP
Dysport  	Dysport  	 NNP	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
included 	included 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
four  	four  	 CD	O
sequential  	sequential  	 CD	B-NP
steps  	steps  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
action  	action  	 NN	O
of  	of  	 IN	O
BoNTA-ABO  	BoNTA-ABO  	 NNS	B-NP
are  	are  	 VBP	O
binding 	binding 	 JJ	O
,  	,  	 ,	O
internalization 	internalization 	 NN	B-NP
,  	,  	 ,	O
translocation 	translocation 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
intracellular  	intracellular  	 JJ	B-NP
proteolysis  	proteolysis  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
target  	target  	 NN	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
all  	all  	 DT	O
BoNT-A  	BoNT-A  	 JJ	B-NP
products  	products  	 NNS	I-NP
must  	must  	 MD	O
meet  	meet  	 VB	O
standards  	standards  	 NNS	O
for  	for  	 IN	O
quality 	quality 	 NN	O
,  	,  	 ,	O
potency 	potency 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
safety 	safety 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
should  	should  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
equivalent  	equivalent  	 JJ	O
formulations  	formulations  	 NNS	B-NP
because  	because  	 IN	O
they  	they  	 PRP	O
have  	have  	 VBP	O
different  	different  	 JJ	O
production  	production  	 NN	B-NP
strains  	strains  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
bacterium  	bacterium  	 NN	O
C  	C  	 NNP	O
botulinum 	botulinum 	 NN	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
different  	different  	 JJ	O
isolation  	isolation  	 NN	O
and  	and  	 CC	O
manufacturing  	manufacturing  	 NN	O
processes  	processes  	 VBZ	O
that  	that  	 DT	O
result  	result  	 NN	O
in  	in  	 IN	O
unique  	unique  	 JJ	O
product  	product  	 NN	B-NP
characteristics 	characteristics 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
production  	production  	 NN	B-NP
steps  	steps  	 NNS	I-NP
for  	for  	 IN	I-NP
Dysport-including  	Dysport-including  	 JJ	I-NP
a  	a  	 DT	O
unique  	unique  	 JJ	O
proprietary  	proprietary  	 JJ	B-NP
purification  	purification  	 JJ	I-NP
process  	process  	 NN	I-NP
using  	using  	 VBG	O
column  	column  	 NN	B-NP
chromatography  	chromatography  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
unique  	unique  	 JJ	O
proprietary  	proprietary  	 NN	O
finishing  	finishing  	 VBG	B-NP
process-result  	process-result  	 JJ	I-NP
in  	in  	 IN	O
consistent  	consistent  	 JJ	O
and  	and  	 CC	O
unique  	unique  	 JJ	O
product  	product  	 NN	B-NP
features 	features 	 NNS	I-NP
.  	.  	 .	O
Studies  	Studies  	 NNS	O
confirm  	confirm  	 VBP	O
that  	that  	 IN	O
Dysport  	Dysport  	 NNP	B-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
high  	high  	 JJ	O
degree  	degree  	 NN	O
of  	of  	 IN	O
long-term  	long-term  	 JJ	O
batch-to-batch  	batch-to-batch  	 JJ	B-NP
consistency  	consistency  	 NN	I-NP
for  	for  	 IN	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
specified  	specified  	 JJ	O
properties 	properties 	 NNS	O
,  	,  	 ,	O
including  	including  	 VBG	O
specific  	specific  	 JJ	O
potency 	potency 	 NN	O
,  	,  	 ,	O
protein  	protein  	 NN	B-NP
composition 	composition 	 NN	I-NP
,  	,  	 ,	O
toxin  	toxin  	 NN	B-NP
complex  	complex  	 JJ	O
charge-density  	charge-density  	 JJ	B-NP
properties 	properties 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
endopeptidase  	endopeptidase  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
native 	native 	 NN	O
,  	,  	 ,	O
natural  	natural  	 JJ	O
form 	form 	 NN	O
,  	,  	 ,	O
NAP  	NAP  	 NNP	O
protect  	protect  	 VB	O
the  	the  	 DT	O
endogenous  	endogenous  	 JJ	B-NP
neurotoxin  	neurotoxin  	 NN	I-NP
from  	from  	 IN	O
degradation  	degradation  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
acidic  	acidic  	 JJ	B-NP
environment  	environment  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
stomach 	stomach 	 NN	O
;  	;  	 :	O
in  	in  	 IN	O
biologic  	biologic  	 JJ	B-NP
formulations 	formulations 	 NNS	I-NP
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
have  	have  	 VB	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
structural  	structural  	 JJ	B-NP
stability 	stability 	 NN	I-NP
,  	,  	 ,	O
binding 	binding 	 JJ	O
,  	,  	 ,	O
uptake 	uptake 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
transcytosis  	transcytosis  	 NN	B-NP
of  	of  	 IN	I-NP
BoNT-A  	BoNT-A  	 JJ	I-NP
products  	products  	 NNS	I-NP
in  	in  	 IN	O
other  	other  	 JJ	O
areas  	areas  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
body 	body 	 NN	O
.  	.  	 .	O
NAP  	NAP  	 NNP	O
are  	are  	 VBP	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
stabilize  	stabilize  	 VB	O
the  	the  	 DT	O
neurotoxin  	neurotoxin  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
vial  	vial  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
product 	product 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
thorough  	thorough  	 JJ	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
action 	action 	 NN	O
,  	,  	 ,	O
product  	product  	 NN	B-NP
characteristics 	characteristics 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
NAP  	NAP  	 NNP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
to  	to  	 TO	O
ensure  	ensure  	 VB	O
appropriate  	appropriate  	 JJ	O
and  	and  	 CC	O
safe  	safe  	 JJ	O
clinical  	clinical  	 JJ	B-NP
use  	use  	 NN	I-NP
of  	of  	 IN	I-NP
BoNT-A  	BoNT-A  	 JJ	I-NP
products 	products 	 NNS	I-NP
.  	.  	 .	O
Now  	Now  	 RB	O
approved  	approved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States 	States 	 NNPS	I-NP
,  	,  	 ,	O
Dysport  	Dysport  	 NNP	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
addition  	addition  	 NN	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
available  	available  	 JJ	O
BoNT-A  	BoNT-A  	 JJ	B-NP
formulations 	formulations 	 NNS	I-NP
.  	.  	 .	O
